These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28975284)

  • 21. Using urine drug testing to support healthy boundaries in clinical care.
    Heit HA; Gourlay DL
    J Opioid Manag; 2015; 11(1):7-12. PubMed ID: 25750160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain.
    Taber L; Lynch SY; He E; Ripa SR
    Postgrad Med; 2016 Jan; 128(1):23-33. PubMed ID: 26681111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid Analgesics.
    Jamison RN; Mao J
    Mayo Clin Proc; 2015 Jul; 90(7):957-68. PubMed ID: 26141334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Containing the opioid overdose epidemic.
    McCarthy M
    BMJ; 2012 Dec; 345():e8340. PubMed ID: 23241432
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing co-occurring substance use and pain disorders.
    Miotto K; Kaufman A; Kong A; Jun G; Schwartz J
    Psychiatr Clin North Am; 2012 Jun; 35(2):393-409. PubMed ID: 22640762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of cigarette smoking on hydrocodone efficacy in chronic pain patients.
    Ackerman WE
    J Ark Med Soc; 2012 Oct; 109(5):90-3. PubMed ID: 23061240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back Pain.
    Wasan AD; Michna E; Edwards RR; Katz JN; Nedeljkovic SS; Dolman AJ; Janfaza D; Isaac Z; Jamison RN
    Anesthesiology; 2015 Oct; 123(4):861-72. PubMed ID: 26375824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canadian approval sought for controversial pain drug.
    Brown C
    CMAJ; 2014 May; 186(8):571. PubMed ID: 24664646
    [No Abstract]   [Full Text] [Related]  

  • 32. All failures count.
    Engel A
    Pain Med; 2015 Feb; 16(2):404. PubMed ID: 25530072
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.
    Rauck RL; Nalamachu S; Wild JE; Walker GS; Robinson CY; Davis CS; Farr SJ
    Pain Med; 2014 Jun; 15(6):975-85. PubMed ID: 24517082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to letter by Dr. Engel.
    Rauck RL
    Pain Med; 2015 Feb; 16(2):404-6. PubMed ID: 25677328
    [No Abstract]   [Full Text] [Related]  

  • 36. Urine and oral fluid drug testing in support of pain management.
    Kwong TC; Magnani B; Moore C
    Crit Rev Clin Lab Sci; 2017 Sep; 54(6):433-445. PubMed ID: 28990451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steering patients to relief from chronic low back pain: opioids' role.
    Chou R
    J Fam Pract; 2013 Mar; 62(3 Suppl):S8-13. PubMed ID: 23520591
    [No Abstract]   [Full Text] [Related]  

  • 38. Zohydro approval by food and drug administration: controversial or frightening?
    Manchikanti L; Atluri S; Candido KD; Boswell MV; Simopoulos TT; Grider JS; Falco FJ; Hirsch JA
    Pain Physician; 2014; 17(4):E437-50. PubMed ID: 25054396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain.
    Hale ME; Zimmerman TR; Ma Y; Malamut R
    J Opioid Manag; 2015; 11(5):425-34. PubMed ID: 26535970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies.
    Volkow ND; McLellan AT
    N Engl J Med; 2016 Mar; 374(13):1253-63. PubMed ID: 27028915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.